Details

Notice - Release of guidance document: Regulatory framework for unauthorized new allergenic products of biological origin used for the diagnosis or treatment of allergic diseases - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 18, 2025 · edition #1
Timestamp: 2025-04-18T22:23:35.066Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/regulatory-framework-unauthorized-allergenic-products-biological-diagnosis-treatment-allergic-diseases.html?wbdisable=false
Replay URL: https://replay.healtharchive.ca/job-1/20250418222335/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/regulatory-framework-unauthorized-allergenic-products-biological-diagnosis-treatment-allergic-diseases.html?wbdisable=false#ha_snapshot=141644
ID: 141644
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots